← FDA Drug Approvals (Drugs@FDA)
DAPTOMYCIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2023-08-07
Drug application
- FDA Application #
ANDA213966- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPTOMYCIN
- Generic name
- DAPTOMYCIN
- Active ingredients
- DAPTOMYCIN
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- MYLAN
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2023-08-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown